Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: Results from the CREDENCE trial and meta-analysis
- CREDENCE Trial Investigators
Research output: Contribution to journal › Article › peer-review
100
Link opens in a new tab
Scopus
citations